{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:00:04Z","timestamp":1775066404994,"version":"3.50.1"},"posted":{"date-parts":[[2026,3,30]]},"group-title":"Cancer Biology","reference-count":30,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 CA276863"],"award-info":[{"award-number":["R01 CA276863"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["F30 CA275327"],"award-info":[{"award-number":["F30 CA275327"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Ionizing radiation can be an effective therapy for prostate cancer. Unfortunately, however, more aggressive prostate cancers such as neuroendocrine prostate cancer (NEPC) are often radiation resistant, which contributes to their high degree of morbidity and mortality. In this study, we used an unbiased approach to identify novel mechanisms that contribute to resistance to radiation and that are associated with neuroendocrine differentiation. Specifically, we compared the expression of cell surface proteins by mass spectrometry in prostate cancer cell lines that had been either untreated or treated with radiation to induce resistance, a process that also promotes neuroendocrine differentiation. Among the proteins identified by this screen, we focused on folate receptor \u03b1 (FR\u03b1) because of its known biological functions and the fact that it is a validated therapeutic target. Our data reveal that FR\u03b1 has a causal role in enabling prostate cancer cells to resist radiation. Importantly, we also demonstrate that the expression of FR\u03b1 is regulated by HIF-1\u03b1, which also has a causal role in radiation resistance and neuroendocrine differentiation. Given that the ability of cells to resist damage and death in response to ionizing radiation depends largely on their ability to buffer the substantial increase in reactive oxygen species (ROS) that is generated by radiation, we also demonstrate that the folate-FR\u03b1 axis promotes radiation resistance by sustaining intracellular glutathione levels that buffer this increase in ROS. In summary, the data reported here highlight a novel role for FR\u03b1 in resistance to ionizing radiation that is intimately associated with the hypoxic microenvironment of NEPC and the ability of the folate-FRa axis to maintain redox homeostasis.<\/jats:p>","DOI":"10.64898\/2026.03.26.714502","type":"posted-content","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:50:21Z","timestamp":1774896621000},"source":"Crossref","is-referenced-by-count":0,"title":["Folate Receptor \u03b1 Contributes to Radiation Resistance in Neuroendocrine Prostate Cancer by Regulating Redox Homeostasis"],"prefix":"10.64898","author":[{"given":"Hira Lal","family":"Goel","sequence":"first","affiliation":[{"name":"Departments of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Radiation Oncology, University of Massachusetts Chan Medical School, Worcester MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris S","family":"Dimitrov","sequence":"additional","affiliation":[{"name":"Departments of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayush","family":"Kumar","sequence":"additional","affiliation":[{"name":"Departments of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christi A","family":"Silva","sequence":"additional","affiliation":[{"name":"Departments of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J","family":"FitzGerald","sequence":"additional","affiliation":[{"name":"Radiation Oncology, University of Massachusetts Chan Medical School, Worcester MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2762-7519","authenticated-orcid":false,"given":"Arthur M.","family":"Mercurio","sequence":"additional","affiliation":[{"name":"Departments of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026040109101546000_2026.03.26.714502v1.1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s43018-022-00355-4","article-title":"MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis","volume":"3","year":"2022","journal-title":"Nat Cancer"},{"key":"2026040109101546000_2026.03.26.714502v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2023.11.006"},{"key":"2026040109101546000_2026.03.26.714502v1.3","doi-asserted-by":"crossref","first-page":"T67","DOI":"10.1530\/ERC-21-0140","article-title":"Therapy considerations in neuroendocrine prostate cancer: what next?","volume":"28","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"2026040109101546000_2026.03.26.714502v1.4","doi-asserted-by":"crossref","first-page":"116543","DOI":"10.1016\/j.celrep.2025.116543","article-title":"Inducing ferroptosis to impede metastasis by inhibiting the calcium channel TRPC6","volume":"44","year":"2025","journal-title":"Cell Rep"},{"key":"2026040109101546000_2026.03.26.714502v1.5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp019"},{"key":"2026040109101546000_2026.03.26.714502v1.6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0729"},{"key":"2026040109101546000_2026.03.26.714502v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08133-6"},{"key":"2026040109101546000_2026.03.26.714502v1.8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00090"},{"key":"2026040109101546000_2026.03.26.714502v1.9","doi-asserted-by":"crossref","unstructured":"Jajja, S.A. , Sodhi, N. , Parent, E.E. , and Singh, P . (2025). PSMA-Directed Theranostics in Prostate Cancer. Biomedicines 13.","DOI":"10.3390\/biomedicines13081837"},{"key":"2026040109101546000_2026.03.26.714502v1.10","doi-asserted-by":"crossref","unstructured":"Kumar, A. , Goel, H.L. , Silva, C.A. , Wang, T. , Geng, Y. , Wang, M. , Goel, S. , Hu, K. , Li, R. , Zhu, L.J. , et al. (2024). Neuropilin-2-expressing breast cancer cells mitigate radiation-induced oxidative stress through nitric oxide signaling. J Clin Invest 134.","DOI":"10.1172\/JCI181368"},{"key":"2026040109101546000_2026.03.26.714502v1.11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s43018-024-00739-8","article-title":"Cycling back to folate metabolism in cancer","volume":"5","year":"2024","journal-title":"Nat Cancer"},{"key":"2026040109101546000_2026.03.26.714502v1.12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41586-025-09727-z","article-title":"NSD2 targeting reverses plasticity and drug resistance in prostate cancer","volume":"649","year":"2026","journal-title":"Nature"},{"key":"2026040109101546000_2026.03.26.714502v1.13","doi-asserted-by":"crossref","unstructured":"Li, Y.F. , Su, S. , Luo, Y. , Wei, C. , He, J. , Song, L.D. , Han, K. , Wang, J. , Gan, X. , and Wang, D.L . (2025). Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review). Oncol Rep 54.","DOI":"10.3892\/or.2025.8942"},{"key":"2026040109101546000_2026.03.26.714502v1.14","doi-asserted-by":"crossref","first-page":"708214","DOI":"10.3389\/fonc.2021.708214","article-title":"Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer","volume":"11","year":"2021","journal-title":"Front Oncol"},{"key":"2026040109101546000_2026.03.26.714502v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.05.007"},{"key":"2026040109101546000_2026.03.26.714502v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(04)00115-1"},{"key":"2026040109101546000_2026.03.26.714502v1.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309169"},{"key":"2026040109101546000_2026.03.26.714502v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2021.12.003"},{"key":"2026040109101546000_2026.03.26.714502v1.19","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1038\/s41598-021-85818-x","article-title":"Folate transporter dynamics and therapy with classic and tumor-targeted antifolates","volume":"11","year":"2021","journal-title":"Sci Rep"},{"key":"2026040109101546000_2026.03.26.714502v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.05.024"},{"key":"2026040109101546000_2026.03.26.714502v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.01.018"},{"key":"2026040109101546000_2026.03.26.714502v1.22","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20537"},{"key":"2026040109101546000_2026.03.26.714502v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2010.08.008"},{"key":"2026040109101546000_2026.03.26.714502v1.24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1518007112"},{"key":"2026040109101546000_2026.03.26.714502v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.09.065"},{"key":"2026040109101546000_2026.03.26.714502v1.26","doi-asserted-by":"crossref","unstructured":"Wang, H. , Jiang, H. , Van De Gucht, M. , and De Ridder, M. (2019). Hypoxic Radioresistance: Can ROS Be the Key to Overcome It? Cancers (Basel) 11.","DOI":"10.3390\/cancers11010112"},{"key":"2026040109101546000_2026.03.26.714502v1.27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-1326"},{"key":"2026040109101546000_2026.03.26.714502v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.virs.2023.04.001"},{"key":"2026040109101546000_2026.03.26.714502v1.29","doi-asserted-by":"crossref","first-page":"678914","DOI":"10.3389\/fimmu.2021.678914","article-title":"Ischemia-Reperfusion Injury Reduces Kidney Folate Transporter Expression and Plasma Folate Levels","volume":"12","year":"2021","journal-title":"Front Immunol"},{"key":"2026040109101546000_2026.03.26.714502v1.30","doi-asserted-by":"crossref","first-page":"637454","DOI":"10.3389\/fcell.2021.637454","article-title":"The Roles of HIF-1alpha in Radiosensitivity and Radiation-Induced Bystander Effects Under Hypoxia","volume":"9","year":"2021","journal-title":"Front Cell Dev Biol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.03.26.714502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:10:29Z","timestamp":1775059829000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.03.26.714502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":30,"URL":"https:\/\/doi.org\/10.64898\/2026.03.26.714502","relation":{},"subject":[],"published":{"date-parts":[[2026,3,30]]},"subtype":"preprint"}}